文献速递心外重症与机械循环支持

模拟试验可否在心源性休克试验中发挥关键作用

Could emulated trials play a key role in cardiogenic shock trials?
PubMed 文献 · J Heart Lung Transplant · 2024-11-04

本文讨论临时机械循环支持(tMCS)用于心源性休克(CS)时证据不足的现状,指出随机对照试验(RCT)在CS情境中受伦理与实施条件限制,提出模拟试验(ET)利用观察性数据模拟理想化RCT设计,可作为RCT的补充评估tMCS的获益与风险。

要点

  • RCT在CS中受伦理与实施条件限制,难以提供充分证据
  • ET利用观察性数据模拟RCT设计,可快速估计风险获益比
  • ET或适用于难治性心脏骤停等不宜随机化的情境

核心结论

  • ET与RCT互为补充,ET可快速评估tMCS用于CS患者的风险获益比,并在不宜随机化的情境中提供参考。

研究设计与样本

  • 本文为论述性文章,未报告系统检索范围、样本量或具体研究设计细节。

主要发现

  • tMCS(含ECLS)已广泛应用于CS患者,但其疗效与安全性证据仍不明确。
  • CS情境下开展RCT面临伦理考量与实施复杂性等挑战。
  • ET通过纳入理想化RCT的设计要素,利用观察性数据在真实情境中评估干预的疗效与安全性。
  • ET可在不遭遇实施障碍的情况下快速估计风险获益比。
  • ET在难治性心脏骤停或「crash and burn」CS等使用tMCS作为最后手段的情境中具有潜在价值。

临床怎么用

  • 对常规使用的tMCS干预,可借助ET早期提示潜在获益,为临床决策提供参考,并与RCT证据互补。

局限性

  • 本文未报告ET的具体方法学细节、样本量或定量结果,相关局限性未在原文中说明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Temporary mechanical circulatory support (tMCS) using extracorporeal life support (ECLS), has been widely implemented in patients with cardiogenic shock (CS), although evidence regarding its efficacy and safety remains unclear. This lack of clarity has recently raised concerns about the role of tMCS in CS management. Conducting randomized controlled trials (RCTs) in the context of CS poses significant challenges due to ethical considerations and logistical complexities. In response to these challenges, emulated trials (ETs) are emerging as a promising alternative. By incorporating design features from idealized RCTs, they use robust and rigorous methods to assess the efficacy and safety of health interventions in real-life settings, using observational data. In our manuscript, we highlight the complementary nature of RCT and ETs by evaluating tMCS for CS patients. While RCTs follow a rigorous experimental design and provide reliable evidence, ETs can swiftly estimate the risk-benefit ratio without encountering logistical barriers thereby offering clinicians' early reassurance about the potential benefits of routinely used interventions. Furthermore, ETs offer potential value in unethical situations (refractory cardiac arrest or "crash and burn" CS) where interventional therapies, such as tMCS, are used as a last resort.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Ughetto A, Nagot N, Delmas C, et al. Could emulated trials play a key role in cardiogenic shock trials? J Heart Lung Transplant. 2024. PMID: 39505059. doi:10.1016/j.healun.2024.10.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。